McDermott et al. examined the predictive value of initial response to buprenorphine-naloxone (i.e., Suboxone) treatment for 12-week treatment outcomes among individuals meeting DSM-IV criteria for opioid dependence (with prescription opioids as the primary substance used).

Predictive Value of Early Abstinence on Medication Assisted Treatment Outcomes: Buprenorphine-Naloxone in Prescription Opioid Users – pharmacology – medication assisted treatment – drugs – alcohol – Addiction – substance use disorder – recoveryanswers – recovery answers – recovery research Institute

March 17, 2017  | 

RESEARCH SUMMARIZED ON Predictive Value of Early Abstinence on Medication Assisted Treatment Outcomes: Buprenorphine-Naloxone in Prescription Opioid Users

SIGN UP FOR THE BULLETIN

  • This field is for validation purposes and should be left unchanged.

151 Merrimac St., 4th Floor. Boston, MA 02114

DONATE
PARTICPATE
Facebook-f Linkedin-in Twitter